Intra-Cellular Therapies, Inc.
METHODS OF SCHIZOPHRENIA TREATMENT
Last updated:
Abstract:
The present disclosure relates to the treatment of schizophrenia in adults, comprising the administration of pharmaceutical capsules comprising 42 mg of lumateperone (60 mg of lumateperone tosylate).
Status:
Application
Type:
Utility
Filling date:
18 Dec 2020
Issue date:
24 Jun 2021